@article{article, title  = {{Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{}},

 year = {{2021}},

 month = {{2}},

 author = {{McCloskey EV and Johansson H and Harvey NC and Lorentzon M and Shi Y and Kanis JA}},

 doi = {{10.1007/s00198-020-05815-0}},

 volume = {{32}},

 journal = {{Osteoporosis International}},

 issue = {{8}},

 pages = {{1601-1608}},

 note = {{Accessed on 2025/12/05}}}